Dahlia Alkekhia

Title: Dahlia Alkekhia: Innovator in Hydrogel Technology

Introduction

Dahlia Alkekhia is a prominent inventor based in Providence, RI (US). She has made significant contributions to the field of hydrogel technology, particularly in the development of responsive materials for medical applications. With a total of 2 patents, her work showcases innovative approaches to addressing challenges in bacterial diagnostics and treatment.

Latest Patents

One of her latest patents is focused on "Bacterial beta-lactamase responsive hydrogels." This invention provides a 'host-guest' supramolecular hydrogel that contains an AAm/NVP interpenetrating polymer network (IPN). The hydrogel is enhanced with supramolecular cross-linkers assembled from a β-lactam/adamantane-containing guest molecule and host polymeric cyclodextrin (PCD). A notable advantage of this hydrogel is its ability to self-heal without external stimuli after being severed, thanks to the molecular association of polymeric cyclodextrin and adamantane. The invention also outlines methods for making the hydrogel, synthesis intermediates, and diagnostic or treatment methods for β-lactamase-containing bacteria.

Another significant patent is the "Chromogenic beta-lactamase substrate." This invention provides a chromogenic β-lactam molecule that retains its diagnostic color change response even when modified for conjugation to another molecule. This innovation enhances the potential for effective bacterial detection and treatment.

Career Highlights

Dahlia Alkekhia is affiliated with Brown University, where she continues to advance her research in hydrogel technology. Her work is characterized by a commitment to developing materials that can significantly impact medical diagnostics and treatment methodologies.

Collaborations

Dahlia collaborates with notable colleagues such as Anita Shukla and Hannah Safford, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Dahlia Alkekhia's contributions to hydrogel technology exemplify the intersection of innovation and practical application in the medical field. Her patents reflect a dedication to improving diagnostic and treatment options for bacterial infections.